Inhibitors of flaviviridae viruses

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8765722
APP PUB NO 20130302280A1
SERIAL NO

13927355

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • GILEAD SCIENCES, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cho, Aesop Mountain View, US 78 2853
Chong, Lee S Newark, US 35 1172
Clarke, Michael O'Neil Hanrahan Redwood City, US 36 669
Doerffler, Edward Union City, US 29 616
Kim, Choung U San Carlos, US 138 3994
Liu, Qi Foster City, US 365 1974
Watkins, William J Saratoga, US 125 2173
Zhang, Jennifer R Foster City, US 61 1556

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 1, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00